Bunazosin + Doxazosin + Valsartin
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
High Blood Pressure
Conditions
High Blood Pressure
Trial Timeline
Oct 1, 2005 → Mar 1, 2009
NCT ID
NCT00130156About Bunazosin + Doxazosin + Valsartin
Bunazosin + Doxazosin + Valsartin is a approved stage product being developed by Eisai for High Blood Pressure. The current trial status is completed. This product is registered under clinical trial identifier NCT00130156. Target conditions include High Blood Pressure.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00130156 | Approved | Completed |
Competing Products
20 competing products in High Blood Pressure